Sentinel Lymph Node Mapping in Esophageal Cancer: Current Status and Future Directions
- PMID: 40402425
- DOI: 10.1245/s10434-025-17479-3
Sentinel Lymph Node Mapping in Esophageal Cancer: Current Status and Future Directions
Abstract
Objective: This review provides a comprehensive discussion about the importance of adequate lymphadenectomy, its anatomic and oncologic significance, principles and rationale of sentinel lymph node mapping, current evidence stratified by tracer substrate, challenges, and future directions. Esophageal cancer has one of the worst cancer-related survival rates, and nodal status is the single most significant prognostic factor. Submucosal penetration generally demands esophagectomy, often following neoadjuvant therapy in the presence of deeper extension. Guidelines recommend resecting ≥15 lymph nodes. Variability in surgical approach and dissection in concert with aberrant esophageal lymphatic anatomy make adequate lymphadenectomy difficult.
Methods: A narrative review was conducted to explore existing literature regarding lymphadenectomy with its requisite anatomic and oncologic significance in esophageal cancer, as well as the rationale for and present state of sentinel lymph node mapping stratified by substrates. Tables and figures were constructed by the authors using Microsoft Office applications and Biorender software, respectively.
Results: Sentinel lymph node mapping exploits the tumoral lymphatic network to identify the nodes most prone to metastasis, directing further dissection. Targeting sentinel lymph nodes with dyes, radiotracers, or hybrid tracers can assist surgeons with lymphadenectomy, potentially improving staging accuracy and personalizing care to individual anatomy.
Conclusions: While this approach would benefit from larger studies and long-term data, early evaluations suggest improved detection of metastases outside the en bloc field without significantly increasing morbidity.
Keywords: Esophageal adenocarcinoma; Esophageal cancer; Esophageal squamous cell carcinoma; ICG; SLN; Sentinel lymph node; Sentinel lymph node mapping.
© 2025. Society of Surgical Oncology.
Conflict of interest statement
Disclosure: Luis Tapias - AstraZeneca (advisory board); Intuitive Surgical (consulting).
Similar articles
-
Pilot-study on the feasibility of sentinel node navigation surgery in combination with thoracolaparoscopic lymphadenectomy without esophagectomy in early esophageal adenocarcinoma patients.Dis Esophagus. 2017 Nov 1;30(11):1-8. doi: 10.1093/dote/dox097. Dis Esophagus. 2017. PMID: 28881907
-
Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.Cochrane Database Syst Rev. 2021 Jun 9;6(6):CD013021. doi: 10.1002/14651858.CD013021.pub2. Cochrane Database Syst Rev. 2021. PMID: 34106467 Free PMC article.
-
Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy.Surg Endosc. 2011 Mar;25(3):817-25. doi: 10.1007/s00464-010-1265-x. Epub 2010 Aug 20. Surg Endosc. 2011. PMID: 20725748 Clinical Trial.
-
Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.Oncologist. 2016 Apr;21(4):461-6. doi: 10.1634/theoncologist.2015-0473. Epub 2016 Mar 9. Oncologist. 2016. PMID: 26961924 Free PMC article.
-
Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.Minerva Chir. 2005 Aug;60(4):217-33. Minerva Chir. 2005. PMID: 16166921 Review. English, Italian.
Cited by
-
ASO Author Reflections: Insights into Sentinel Lymph Node Mapping for Esophageal Cancer.Ann Surg Oncol. 2025 Aug;32(8):5970-5971. doi: 10.1245/s10434-025-17577-2. Epub 2025 May 30. Ann Surg Oncol. 2025. PMID: 40445507 No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials